Disorders of Neuromuscular Transmission Caused by Drugs
- 23 August 1979
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 301 (8) , 409-413
- https://doi.org/10.1056/nejm197908233010805
Abstract
MORE than 30 drugs in current clinical use, other than those used in anesthesia, may interfere with neuromuscular transmission. This complication of drug therapy is unusual but has been well documented; over 200 cases have been reported.1 Awareness of the possibility of such an effect is important, since failure to recognize that a drug is responsible for, or is contributing to, a myasthenic syndrome may lead to unnecessary morbidity and even to a fatal outcome in what is potentially a reversible condition. Although clinically manifest neuromuscular blockade is uncommon, subclinical involvement is probably more frequent than is generally appreciated.Clinical . . .Keywords
This publication has 37 references indexed in Scilit:
- The action of chlorpromazine at an isolated cholinergic synapseBrain Research, 1979
- DRUG-INDUCED DISORDERS OF NEUROMUSCULAR TRANSMISSIONAdverse Drug Reaction Bulletin, 1979
- Depression of synaptic transmission by diphenylhydantoinAnnals of Neurology, 1977
- The site of the neuromuscular block produced by polymyxin B and rolitetracyclineCanadian Journal of Physiology and Pharmacology, 1976
- Emergence of Myasthenia Gravis During Treatment With Lithium CarbonateArchives of General Psychiatry, 1976
- β-Blockers and Myasthenia GravisAnnals of Internal Medicine, 1975
- The Mechanism of Acute Neuromuscular Weakness Induced by ChloroquineCanadian Journal of Physiology and Pharmacology, 1972
- Propranolol, a curariform and cholinomimetic agent at the frog neuromuscular junctionComparative and General Pharmacology, 1971
- The Nature of the Neuromuscular Block Produced by NeomycineActa Physiologica Scandinavica, 1962
- MASKED MYASTHENIA GRAVISJAMA, 1949